Eco Animal Health Group PLC Clarification of new long term incentive plan (3621Q)

TIDMEAH

RNS Number : 3621Q

Eco Animal Health Group PLC

25 February 2021

25 February 2021

ECO Animal Health Group plc

("ECO", "the Company" or the "Group")

(AIM: EAH)

CLARIFICATION OF NEW LONG TERM INCENTIVE PLAN

ECO Animal Health Group plc announces a clarification in respect of the new Long Term Incentive Plan ("LTIP") to be proposed at the upcoming General Meeting of the company on 4 March 2021.

Following consultation with a sample of shareholders, the LTIP scheme rules were drawn up by independent respected remuneration consultants and are designed to be compliant with best practice for AIM quoted companies. The LTIP scheme rules include standard wording present in all such best-in-class schemes which provide the ECO Remuneration Committee with discretion to amend the vesting in the event of an anomalous outcome.

In response to questions received from shareholders and publication of ISS Proxy Analysis & Benchmark Policy Voting Recommendations report, the Independent Remuneration Committee of the Company confirms that all awards under the LTIP will have performance conditions attached.

Contacts:

 
ECO Animal Health Group plc 
 Marc Loomes (CEO) 
 Christopher Wilks (CFO)                020 8447 8899 
IFC Advisory 
 Graham Herring 
 Zach Cohen                             020 3934 6630 
N+1 Singer (Nominated Adviser & Joint 
 Broker) 
 Mark Taylor 
 Peter Steel 
 Iqra Amin                              020 7496 3000 
Peel Hunt LLP (Joint Broker) 
 James Steel 
 Dr Christopher Golden                  020 7418 8900 
 

ECO Animal Health Group plc ("ECO" or "the "GROUP") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCFELFLFLLFBBF

(END) Dow Jones Newswires

February 25, 2021 06:15 ET (11:15 GMT)